drugset / Trial / NCT00409643

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

NCT00409643

Phase 3 Completed 1259 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial will compare valsartan and amlodipine combination therapies to valsartan and amlodipine monotherapy,and placebo for treating patients with hypertension

Timeline

Start
2004-01
Primary completion
2004-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg
Subject Valsartan Small molecule 160 mg
Subject Valsartan Small molecule 320 mg

Indications